Safety and feasibility of physiotherapy in ICU-admitted severe COVID-19 patients: an observational study

Veronica Rossi1, Martina Santambrogio2, Cesare Del Monaco3

  • 1Health Professions Department Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan. veronica.rossi@policlinico.mi.it.

Insights

Early physiotherapy is safe and feasible for severe COVID-19 patients in intensive care units (ICUs). This intervention, though delayed, aids in recovery and mobilization for critically ill individuals.

Area of Science:

  • Critical Care Medicine
  • Rehabilitation Medicine
  • Infectious Diseases

Background:

  • Severe COVID-19 often leads to prolonged intensive care unit (ICU) stays, resulting in significant deconditioning.
  • The role and safety of early physiotherapy in managing severe coronavirus disease 2019 (COVID-19) patients remain unclear.
  • Understanding the specific interventions and outcomes is crucial for optimizing patient recovery.

Purpose of the Study:

  • To describe the physiotherapy interventions provided to severe COVID-19 patients requiring invasive mechanical ventilation.
  • To evaluate the safety and feasibility of early physiotherapy in this population.
  • To analyze the timing of interventions and patient mobilization milestones.

Main Methods:

  • A consecutive series of adult patients with confirmed SARS-CoV-2 infection admitted to the ICU and requiring mechanical ventilation for over 24 hours were enrolled.
  • Physiotherapy sessions were monitored for adverse events.
  • Data collected included the type and timing of physiotherapy, time to first mobilization, standing, and walking, and functional assessments at hospital discharge.

Main Results:

  • Eighty-four severe COVID-19 subjects were included, with few minor adverse events reported, indicating safety.
  • Active mobilization was prioritized over passive, supporting independence in daily activities.
  • The median time from intubation to first physiotherapy was 13 days, and to walking was 27 days.
  • Tracheostomy was associated with delayed mobilization (sit out of bed, ambulation) but not with differences in 6-minute walk test (6MWT) or 1-meter sit-to-stand test (1m-STST) performance.

Conclusions:

  • Early physiotherapy is a feasible and safe intervention for severe COVID-19 patients in the ICU, benefiting both patients and healthcare workers.
  • While safe, physiotherapy delivery was observed to be delayed compared to non-COVID-19 critically ill patients.
  • Further research may optimize the timing and delivery of physiotherapy to improve outcomes for these patients.

Related Concept Videos

Flail Chest-II01:26

Flail Chest-II

Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
274
Chest Physiotherapy01:24

Chest Physiotherapy

Chest Physiotherapy (CPT) is a therapeutic technique used in respiratory care to improve ventilation, clear bronchial secretions, and enhance the efficiency of respiratory muscles. This therapy includes three primary procedures: postural drainage, percussion, and vibration. It can be performed on spontaneously breathing patients and those who are intubated and mechanically ventilated.
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
863
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
45
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
417
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
63
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
382